The U.S. Department of Homeland Security adds three Chinese genomics companies to the Uyghur Forced Labor Prevention Act Entity List, triggering import limits tied to allegations of forced labor.
The New York Times reports the action restricts trade with BGI, a major Chinese genomics firm, and says U.S. officials link the company to forced labor and abuse of minority groups. Channel NewsAsia likewise describes a ban on imports from three Chinese genomics companies, also citing forced labor. The Washington Times focuses on the same DHS listing, describing the three companies being added to the entity list.
Across outlets, the core details are consistent: the U.S. uses the Uyghur Forced Labor Prevention Act framework to target specific Chinese genomics firms, and the restrictions are presented as a way to block shipments connected to the alleged forced labor of Uyghurs and other minority groups.
